Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Agilent to Announce Fourth-Quarter Fiscal Year 2022 Financial Results Nov. 21
Agilent to Announce Fourth-Quarter Fiscal Year 2022 Financial Results Nov. 21


Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the fourth quarter of fiscal year 2022 after the stock market closes on Monday, Nov. 21. The company will

Premier, Inc. Reports Fiscal Year 2023 First Quarter Results
Premier, Inc. Reports Fiscal Year 2023 First Quarter Results


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2023 first quarter ended September 30, 2022.



"Our

Dexcom Reports Third Quarter 2022 Financial Results
Dexcom Reports Third Quarter 2022 Financial Results


DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2022.



Third Quarter 2022 Financial Highlights:




  • Revenue grew 18% versus the same

Dexcom Reports Third Quarter 2022 Financial Results
Dexcom Reports Third Quarter 2022 Financial Results


DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2022.



Third Quarter 2022 Financial Highlights:




  • Revenue grew 18% versus the same

Labcorp Announces 2022 Third Quarter Results
Labcorp Announces 2022 Third Quarter Results


Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022, and updated full-year guidance.



"Labcorp made important strategic

EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial
Simulations Plus Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results
Simulations Plus Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its fourth

Humana, Monogram Health Announce New Agreement that Enhances In-home Kidney Care in Four States
Humana, Monogram Health Announce New Agreement that Enhances In-home Kidney Care in Four States


Kidney care provider Monogram Health and leading health and well-being company Humana Inc. (NYSE: HUM) have announced a new value-based care agreement for most Humana Medicare Advantage HMO and PPO

Humana expands Medicare Advantage health plan offerings into Rhode Island, Wyoming and 140 new counties nationwide in 2023
Humana expands Medicare Advantage health plan offerings into Rhode Island, Wyoming and 140 new counties nationwide in 2023


Leading health and well-being company Humana Inc. (NYSE: HUM) is offering Medicare Advantage plans for the first time in two new states and 140 new U.S. counties, expanding cost-effective health

Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. Declares Quarterly Cash Dividend


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common

Simulations Plus Announces Cash Dividend
Simulations Plus Announces Cash Dividend


Simulations Plus, Inc. (Nasdaq: SLP) announced today that the Company’s Board of Directors has declared a cash dividend of $0.06 per share of the Company’s common stock, payable on November 7

STAAR Surgical to Report Third Quarter Results on November 2, 2022
STAAR Surgical to Report Third Quarter Results on November 2, 2022


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release

Premier, Inc. Issues 2022 Sustainability Report
Premier, Inc. Issues 2022 Sustainability Report


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today released its 2022 Sustainability Report detailing its companywide initiatives focused on

Premier, Inc.'s Subsidiary Contigo Health, LLC, Completes Asset Transaction for National Provider Contracts and Licenses to Cost Containment Technology
Premier, Inc.'s Subsidiary Contigo Health, LLC, Completes Asset Transaction for National Provider Contracts and Licenses to Cost Containment Technology


Premier, Inc. (NASDAQ: PINC) subsidiary Contigo Health, LLC, a provider of comprehensive services that optimize employee health benefits, today closed its transaction to acquire key assets from

EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022


QuidelOrtho Corporation (NASDAQ: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and

Simulations Plus Releases GastroPlus® Version 9.8.3
Simulations Plus Releases GastroPlus® Version 9.8.3


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of version 9.8.3 of its

Agilent Opens Center of Excellence for Dissolution Products:
Agilent Opens Center of Excellence for Dissolution Products


Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly modernized premises will house the

Humana, USAA Launch New Medicare Advantage Plan Tailored to Veterans’ Needs
Humana, USAA Launch New Medicare Advantage Plan Tailored to Veterans’ Needs


Humana Inc. (NYSE: HUM) and USAA Life Insurance Company (USAA Life) announced a new Medicare Advantage plan designed with veterans in mind to provide a robust coverage option that complements

Spatial Imaging of 1,000 RNAs and 100 Proteins Using the CosMx Spatial Molecular Imager Published in Nature Biotechnology
Spatial Imaging of 1,000 RNAs and 100 Proteins Using the CosMx Spatial Molecular Imager Published in Nature Biotechnology


NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of its first paper describing the

Simulations Plus Sets Date for Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call
Simulations Plus Sets Date for Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call


Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its fourth quarter and full year financial results for fiscal year 2022, the period ended August 31, 2022, after the close

Acadia Healthcare Announces Date for Third Quarter 2022 Earnings Release
Acadia Healthcare Announces Date for Third Quarter 2022 Earnings Release


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2022 results on Monday, October 31, 2022, after the close of the market. Acadia will conduct a

EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility
EQS-News: Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility